Telemedicine for hf management

Access through your institution Buy or subscribe Use of remote patient management reduces the unplanned time spent in hospital for cardiovascular reasons as well as all-cause mortality

compared with usual care when used in well-defined, selected populations of patients with heart failure (HF). These findings from the TIM-HF2 trial were presented at the 2018 ESC Congress.

The trial included 1,571 patients with NYHA class II–III HF and left ventricular ejection fraction ≤45% (or >45% if receiving oral diuretics) who had been admitted to hospital for HF

within 12 months before randomization. Patients were randomly assigned to remote patient management plus usual care or to usual care only, with up to 393 days of follow-up. The approach

involved daily transmissions to a telemedical centre of data on bodyweight, blood pressure, heart rate, heart rhythm, and peripheral capillary oxygen saturation measured with a

telemonitoring system in the patient’s home, as well as a self-rated health status. A risk profile was defined for each patient with the use of algorithms and biomarker data obtained at

follow-up visits, which enabled staff to provide tailored patient management such as changes in medication, admission to hospital, or educational activities. This is a preview of

subscription content, access via your institution ACCESS OPTIONS Access through your institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value

online-access subscription $32.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more

Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS:

* Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES ORIGINAL ARTICLE * Koehler, F. et al. Efficacy of telemedical interventional

management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial. _Lancet_ https://doi.org/10.1016/S0140-6736(18)31880-4 (2018) Article  PubMed 

Google Scholar  Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Nature Reviews Cardiology http://www.nature.com/nrcardio/ Irene Fernández-Ruiz Authors * Irene

Fernández-Ruiz View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Irene Fernández-Ruiz. RIGHTS AND PERMISSIONS

Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Fernández-Ruiz, I. Telemedicine for HF management. _Nat Rev Cardiol_ 15, 656 (2018). https://doi.org/10.1038/s41569-018-0094-9

Download citation * Published: 17 September 2018 * Issue Date: November 2018 * DOI: https://doi.org/10.1038/s41569-018-0094-9 SHARE THIS ARTICLE Anyone you share the following link with will

be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt

content-sharing initiative